dalfampridine

FDA Drug Profile

Drug Details

Generic Name
dalfampridine
Brand Names
N/A
Application Number
Sponsor
Jubilant Biosys limited
NDC Codes
1
Dosage Forms
POWDER
Routes
N/A
Active Ingredients
DALFAMPRIDINE

Indications and Usage

1 INDICATIONS AND USAGE Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies (14) ]. Dalfampridine is a potassium channel blocker indicated to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed ( 1 , 14 ).